## Mechanism of NSAID Action **Key Point:** NSAIDs inhibit cyclooxygenase (COX) enzymes, but the nature of inhibition differs by drug class. ### COX Inhibition: Reversible vs Irreversible | Feature | Most NSAIDs | Aspirin | |---------|-------------|----------| | Type of inhibition | Reversible, competitive | Irreversible, covalent | | Duration of effect | Short (hours to days) | Long (7–10 days for platelets) | | Recovery mechanism | Enzyme dissociation | New protein synthesis required | | Platelet recovery | Within 24–48 hours | 7–10 days | **High-Yield:** Aspirin is the ONLY NSAID that irreversibly acetylates COX enzymes. All other NSAIDs (ibuprofen, naproxen, indomethacin, meloxicam, etc.) are reversible, competitive inhibitors. ### COX-1 vs COX-2 Selectivity and Clinical Effects **Key Point:** Both COX-1 and COX-2 inhibition contribute to therapeutic and adverse effects. - **COX-1 inhibition** → decreased thromboxane A₂ (TXA₂) in platelets → antiplatelet effect (correct) - **COX-2 inhibition** → decreased prostaglandin E₂ (PGE₂) and prostacyclin → analgesic, anti-inflammatory, antipyretic effects (correct) - **COX-1 inhibition** → decreased protective PGE₂ in gastric mucosa → increased ulcer risk (correct) **Clinical Pearl:** Selective COX-2 inhibitors (coxibs: celecoxib, rofecoxib) reduce GI toxicity by sparing COX-1–mediated gastric protection, but increase cardiovascular thrombotic risk due to unopposed TXA₂ (correct statement). ### Why the Correct Answer is Wrong The statement "NSAIDs inhibit prostaglandin synthesis by **irreversibly** blocking the active site of cyclooxygenase enzymes" is FALSE. Only **aspirin** achieves irreversible inhibition through acetylation of serine residues. All other NSAIDs are reversible, competitive inhibitors that dissociate from the enzyme. **Mnemonic:** **ASPIRIN = Acetylates Serine, Permanent Irreversible Reaction IN NSAIDs** — it's the exception, not the rule. [cite:KD Tripathi 8e Ch 12]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.